The global patient engagement solutions market size was valued at USD 15.6 billion in 2020, and is predicted to be worth around USD 70.2 billion by 2030, registering a CAGR of 17.3% during the forecast period 2022 to 2030.
Growth Factors
The key factors fueling the market growth include rising digitalization across healthcare, increasing prevalence of chronic conditions, and technological advancements. The COVID-19 pandemic boosted digitalization across healthcare. This, in turn, has fueled the awareness and adoption of patient engagement solutions, thus propelling the market growth.
Growing technological developments, adoption of EHR and mhealth solutions, the prevalence of chronic diseases, supportive initiatives by key market stakeholders, and consumerism in healthcare are some of the key drivers of this market. As per a 2021 survey by NextGen Healthcare,83% of ambulatory healthcare survey respondents believed that patient engagement solutions played a key role in organizational financial success and patient outcomes. The survey also indicated that the COVID-19 pandemic fueled the market growth.
The COVID-19 pandemic has made unprecedented consequences on daily lives in addition to the worldwide economy. A significant burden is formed on healthcare systems across the globe. Providers, payers, and life science companies began looking for solutions to increase engagement with patients in various settings such as remote home monitoring, virtual consultations, and clinical trials.
Report Coverage
Report Scope | Details |
Market Size | US$ 70.2 billion by 2030 |
Growth Rate | CAGR of 17.3% From 2022 to 2030 |
Largest Market | North America |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segments Covered | Delivery Type, Component, Functionality, Therapeutic Area, Application, End user |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Mentioned | Cerner Corporation (Oracle); NextGen Healthcare, Inc.; Epic Systems Corporation; Allscripts Healthcare, LLC; McKesson Corporation; ResMed; Koninklijke Philips N.V.; Klara Technologies, Inc.; CPSI; Experian Information Solutions, Inc.; athenahealth, Inc.; Solutionreach, Inc.; IBM; MEDHOST; Nuance Communications, Inc. |
By Delivery Type Analysis
The web and cloud-based segment dominated the market in 2021 with a revenue share of over 75.0%. The segment is also anticipated to expand at the fastest rate over the forecast period.
The platform is intended to aid providers to advance patient engagement and association among health teams with features such as telehealth and data analytics. On-premise services provide patient data security, easy retrieval, and ease of access.
By Component Analysis
The software and hardware segment accounted for the largest share of over 60.0% in 2021 and is expected to expand at the fastest CAGR over the forecast period. Patient engagement software and hardware form the core offering of the solution.
The services segment is one of the crucial parts of the effective operation of patient engagement solutions. It helps in leveraging and optimizing patient engagement solutions as per the customer needs and to maximize patient health outcomes.
By Functionality Analysis
The communication segment accounted for the largest revenue share of over 35.0% in 2021 as it forms the core offering of any patient engagement solution. This large share is attributed to a surge in demand and adoption of telehealth, mhealth, and other virtual communication solutions via audio, video, and text.
The health tracking and insights segment is projected to grow at the fastest rate of 18.8% over the forecast period. This is owing to the increasing integration of data analytics, AI, and machine learning to present actionable insights to patients and their care providers.
By Therapeutic Area Analysis
Chronic disease management dominated the market in 2021 with a revenue share of over 40.0%. The rising geriatric population in key markets, the prevalence of chronic diseases, and the adoption of digital technologies catalyzed by the COVID-19 pandemic have contributed to the large share of the segment.
The health and wellness segment is anticipated to expand at the fastest rate of 17.7% over the forecast period. This is owing to the initiatives by key companies, the expansion of product offerings to cover mental health, weight management, and pregnancy, and increasing research activities.
By Application Analysis
The outpatient health management segment dominated the market and held a revenue share of over 35.0% in 2021. The others application segment, which includes R&D and preventive care, is anticipated to expand at the fastest rate of 17.7% over the forecast period.
Patient engagement solutions also help the patients to connect with their healthcare providers from remote locations, thereby enabling the streamlined flow of information, patient feedback, and other health-related data.
By End-user Analysis
Providers held the largest revenue share of over 45.0% in 2021. Providers serve the largest volume of patients and are also the primary line of treatment for consultation from general to specialist health concerns. These end users are thus the largest adopters of patient engagement solutions.
The payers end-user segment is estimated to expand at the fastest rate of 17.6% over the forecast period. The growth of the payers segment can be attributed to the increasing adoption of patient and customer engagement solutions that promote widespread coverage and enable value-based care delivery.
By Regional Analysis
North America held the largest revenue share of over 35.0% in 2021 due to the presence of key players, increasing adoption of mhealth and EHR, and growing investment in patient engagement software by the major companies.
The Asia Pacific market is expected to register a lucrative growth rate of 18.8% during the estimated period. The growing penetration of the internet and smartphone users, a large patient population, improving healthcare infrastructure and care quality, and the presence of local players are some of the key factors that are anticipated to offer lucrative growth opportunities to the market over the forecast period.
Key Players
Cerner Corporation (Oracle)
NextGen Healthcare, Inc.
Epic Systems Corporation
Allscripts Healthcare, LLC
McKesson Corporation
ResMed
Koninklijke Philips N.V.
Klara Technologies, Inc.
CPSI
Experian Information Solutions, Inc.
athenahealth, Inc.
Solutionreach, Inc.
IBM
MEDHOST
Nuance Communications, Inc.
Market Segmentation
By Delivery Type
Web & Cloud-based
On-premise
By Component
Software & Hardware
Standalone
Integrated
Services
Consulting
Implementation & Training
Support & Maintenance
Others
By Functionality
Communication
Health Tracking & Insights
Billing & Payments
Administrative
Patient Education
Others
By Therapeutic Area
Health & Wellness
Chronic Disease Management
Others
By Application
Population Health Management
Outpatient Health Management
In-patient Health Management
Others
End-user
Payers
Providers
Others
Regional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Netherlands
Sweden
Russia
Asia Pacific
China
India
Japan
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
Saudi Arabia
Israel
UAE
The patient engagement solutions market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of patient engagement solutions market for the base year 2021 and the forecast between 2022 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global patient engagement solutions market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the patient engagement solutions market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted patient engagement solutions market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the patient engagement solutions capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of patient engagement solutions by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global patient engagement solutions market. These figures have been provided in terms of both revenue and volume for the period 2019 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major patient engagement solutions market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of patient engagement solutions market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the patient engagement solutions industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
patient engagement solutions market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to patient engagement solutions market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of patient engagement solutions market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new patient engagement solutions market. These factors have benefited the growth of the global market for patient engagement solutions. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for patient engagement solutions. The global market is segmented on the basis of region, application, end-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of patient engagement solutions are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Patient Engagement Solutions Market, By Delivery Type
7.1. Patient Engagement Solutions Market, by Delivery Type, 2021-2030
7.1.1. Web & Cloud-based
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. On-premise
7.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global Patient Engagement Solutions Market, By Application
8.1. Patient Engagement Solutions Market, by Application, 2021-2030
8.1.1. Software & Hardware
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Services
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Patient Engagement Solutions Market, By Functionality
9.1. Patient Engagement Solutions Market, by Functionality, 2021-2030
9.1.1. Communication
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Health Tracking & Insights
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Billing & Payments
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Administrative
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Patient Education
9.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Patient Engagement Solutions Market, By Therapeutic Area
10.1. Patient Engagement Solutions Market, by Therapeutic Area, 2021-2030
10.1.1. Health & Wellness
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Chronic Disease Management
10.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Patient Engagement Solutions Market, By Application
11.1. Patient Engagement Solutions Market, by Application, 2021-2030
11.1.1. Population Health Management
11.1.1.1. Market Revenue and Forecast (2019-2030)
11.1.2. Outpatient Health Management
11.1.2.1. Market Revenue and Forecast (2019-2030)
11.1.3. In-patient Health Management
11.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 12. Global Patient Engagement Solutions Market, By End-user
12.1. Patient Engagement Solutions Market, by End-user, 2021-2030
12.1.1. Payers
12.1.1.1. Market Revenue and Forecast (2019-2030)
12.1.2. Providers
12.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 13. Global Patient Engagement Solutions Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.1.2. Market Revenue and Forecast, by Application (2019-2030)
13.1.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.1.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.1.5. Market Revenue and Forecast, by Application (2019-2030)
13.1.6. Market Revenue and Forecast, by End-user (2019-2030)
13.1.7. U.S.
13.1.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.1.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.1.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.1.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.1.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.1.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.1.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.1.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.1.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.1.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.1.8.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2.7. UK
13.2.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2.8. Germany
13.2.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.8.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2.9. France
13.2.9.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.9.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.9.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.9.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.9.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.9.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2.10. Rest of Europe
13.2.10.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.10.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.10.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.10.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.10.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.10.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3.7. India
13.3.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.8.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3.9. Japan
13.3.9.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.9.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.9.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.9.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.9.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.9.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3.10. Rest of APAC
13.3.10.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.10.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.10.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.10.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.10.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.10.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4.7. GCC
13.4.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.8.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4.9. South Africa
13.4.9.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.9.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.9.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.9.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.9.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.9.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4.10. Rest of MEA
13.4.10.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.10.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.10.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.10.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.10.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.10.6. Market Revenue and Forecast, by End-user (2019-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.5.2. Market Revenue and Forecast, by Application (2019-2030)
13.5.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.5.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.5.5. Market Revenue and Forecast, by Application (2019-2030)
13.5.6. Market Revenue and Forecast, by End-user (2019-2030)
13.5.7. Brazil
13.5.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.5.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.5.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.5.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.5.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.5.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.5.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.5.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.5.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.5.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.5.8.6. Market Revenue and Forecast, by End-user (2019-2030)
Chapter 14. Company Profiles
14.1. Cerner Corporation (Oracle)
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. NextGen Healthcare, Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Epic Systems Corporation
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Allscripts Healthcare, LLC
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. McKesson Corporation
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. ResMed
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Koninklijke Philips N.V.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Klara Technologies, Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. CPSI
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Experian Information Solutions, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms